⇚ Regimen IMFINZI® Maintenance - Small Cell Lung Cancer Medical Name IMFINZI® (Durvalumab) Maintenance treatment - for Extensive Stage Small Cell Lung Cancer Cycles Given 24 Delivery Phases N/A Special Instructions Treatment started after completion of 4 cycles of chemoimmunotherapy and continued until disease progression or unacceptable toxicity. Monitor closely for immune mediated end organ damage such as Pneumonitis, Colitis, Hepatitis, Endocrinopathies and Nephritis. References Paz-Ares L, et al. Lancet 2019 - VIEW External References http://www.ncbi.nlm.nih.gov/pubmed/31590988 - VIEW Drug Mode Given Standard Dose Days to Be Given Frequency Solution Volume Duration IMFINZI® (Durvalumab) IV 1500 mg D1 q28 NSS 250 cc 60 minutes